Enjoy complimentary customisation on priority with our Enterprise License!
The global human immunodeficiency virus (HIV) rapid test kits market size is estimated to grow by USD 294.96 million at a CAGR of 6.52% between 2023 and 2028.
Human immunodeficiency virus (HIV) rapid test kits market Share
For More Highlights About this Report, Download Free Sample in a Minute
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The high prevalence of HIV is the key factor driving market growth. AIDS, driven by HIV infection, has become a global health hazard, leading to millions of individuals being diagnosed with the disease. The vast majority of people living with HIV infection are from low- and middle-income countries. The Sub-Saharan African region and Asia-Pacific regions are greatly impacted by the disease. In this regard, many market players are offering innovative and efficient products for HIV diagnosis.
For example, QIAGEN offers Artus HI Virus-1 RT-PCR Kits CE, which provides reliable HIV-1 RNA detection and quantitation for in-vitro diagnostic use. The kit uses manual sample preparation and assay setup techniques. The kit offers a Complete Conformite Europeene - in-vitro Diagnostic device (CE-IVD) compliant workflow from sample collection to detection. Hence, such factors are expected to drive the growth of the market during the forecast period.
Efforts to increase pre-marital screenings for HIV is the primary trend shaping market growth. Despite the implementation of various prevention measures to mitigate HIV, every year, millions of individuals become infected by it. Thus, to control and prevent this global health threat, many policies and initiatives have been examined and enforced by different governments across the globe. One such initiative includes pre-marital screening.
Moreover, pre-marital screening test includes a health assessment of soon-to-be-married couples to identify the presence of infectious, genetic diseases and STDs to prevent further risk of transmitting any disease between couples and their children. With growing awareness about the benefits of pre-marital screening, there has been a rise in such testing programs. Hence, the rising focus on pre-marital screening for HIV will drive the growth of the market during the forecast period.
Limited healthcare services in developing regions is a challenge that affects market growth. A considerable population in developing regions such as Asia-Pacific, the Middle East, and Africa neither have good knowledge about health problems nor admission to healthcare facilities. This movement is prevalent due to a lack of financial and human resources, which is a major obstacle to the promotion of public health and thus increases the HIV-infected population.
Furthermore, developing countries such as Kenya, Algeria, Afghanistan, and Bangladesh lack technology, infrastructure, and adequate policies to ensure efficient healthcare service delivery. The prevalence of HIV causes high rates of mortality and morbidity, and a lack of financial resources for infrastructure and health systems may impede human immunodeficiency virus rapid test kits market growth. Hence, such factors will adversely affect the growth of the market during the forecast period.
The end-user segment includes diagnostic centers, hospitals, and clinics. The type segment includes HIV rapid immunoassay test and HIV rapid molecular diagnostic test. The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW).
The market share growth by the diagnostic centers segment will be significant during the forecast period. The raised awareness among the population pertaining to the benefits of early detection of HIV, the availability of a broad range of HIV rapid tests, and the rising number of healthcare settings offering HIV rapid tests are some of the main attributes that are contributing to the demand for HIV diagnostic services involving HIV rapid test kits. These test kits are used widely to conduct HIV detection tests in diagnostic centers, which is propelling the growth of the HIV rapid test kits market.
Get a glance at the market contribution of various segments Download the PDF Sample
The diagnostic centers segment was valued at USD 369.385 million in 2018. One of the important aspects to be followed at diagnostic centers performing HIV rapid tests is quality assurance testing. A quality assurance program must be performed in every diagnostic center to continuously assess and enhance the processes that are essential in the production of laboratory results. Therefore, the diagnostic centers segment will grow significantly in the global human immunodeficiency virus (HIV) rapid test kits market during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The rising incidence of HIV in North America has spurred demand for rapid HIV test kits, ensuring prompt medical intervention. In the US, CDC data from June 2020 revealed 1.1 million diagnosed HIV cases by the end of 2020, escalating the need for immediate diagnosis. The proliferation of healthcare providers offering STD testing services aligns with CDC recommendations for routine HIV testing, contributing to increased HIV testing demand. Various government and non-government organizations, like the Minority HIV/AIDS Fund and the International Antiviral Society-USA, are actively involved in HIV prevention efforts. In Canada, the Federal Initiative to Address HIV/AIDS aims to mitigate the disease's impact through funding and awareness programs. Mexico's AIDS Healthcare Foundation and the International AIDS Society further contribute to heightened HIV awareness, treatment, and prevention, fostering market growth.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
AccuQuik Test Kits: The company offers human immunodeficiency virus (HIV) rapid test kits, namely AccuQuik, which is a chromatographic immunoassay for the qualitative detection of antibodies raised against human immunodeficiency virus in human serum, plasma or blood.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Scope |
|
Report Coverage |
Details |
Page number |
164 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.52% |
Market growth 2024-2028 |
USD 294.96 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.45 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 40% |
Key countries |
US, Canada, UK, Germany, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, AccuQuik Test Kits, Amkay Products Pvt. Ltd., Becton Dickinson and Co., Bhat Bio Tech India Pvt Ltd., bioLytical Laboratories Inc., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DrSafeHands, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Healgen Scientific, LLC, Hologic Inc., J. Mitra and Co. Pvt. Ltd., MP Biomedicals Inc., Oragenics Inc., OraSure Technologies Inc., Pathkits Heathcare Pvt. Ltd., and SHINE SA |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.